Chimerix hires new CEO, chief business officer

The biopharmaceutical company appointed Michael A. Sherman, former CEO of Endocyte Inc., as CEO. It also appointed Michael T. Andriole, former chief financial officer of Endocyte Inc., to the newly created position of chief business officer.

Read More